Also, Ahmadvand S et al. reported that CD3+, CD8+, Foxp3+ and CD45RO+ TILs in mammary carcinoma serve as prognostic predictors for disease-free survival (DFS) and overall survival (OS). The gene discussed is CD8A; the disease is breast carcinoma.